1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2.Outcome and clinical features of 8 patients with acute stroke and occluded internal carotid/middle cerebral arteries
Case No Initial NIHSS 24-Hour NIHSS 1-Month Outcome NIHSS/mRS 3-Month Outcome NIHSS/mRS Thrombolytic Agent Route/Dose of rtPA/mg Post Thrombolysis TIMI /MCA 1 8 4 1/1 1/1 IA 25 2 2 15 12 5/2 4/2 IA 8 2 3 21 7 3/1 3/1 IV 8.7/IA 15 3 4 16 8 5/2 5/2 IV 7.5/IA 15 1 5 14 2 2/1 1/0 IV 49.2/IA 2 2 6 18 14 5/2 3/1 IV 60/IA 15 2 7 8 1 1/0 1/0 IA 10 2 8 7 2 1/0 1/0 IA 4 3
Note:—NIHSS indicates National Institutes of Health Stroke Scale; mRS, modified Rankin scale; IA, intra-arterial; rtPA, tissue plasminogen activation; TIMI, Thrombolysis in Myocardial Infarction Scores; MCA, middle cerebral artery; IV, intravenous.